Identification of four genes as novel susceptibility loci for early-onset type 2 diabetes mellitus, metabolic syndrome, or hyperuricemia

@article{Yamada2018IdentificationOF,
  title={Identification of four genes as novel susceptibility loci for early-onset type 2 diabetes mellitus, metabolic syndrome, or hyperuricemia},
  author={Yoshiji Yamada and Kimihiko Kato and Mitsutoshi Oguri and Hideki Horibe and Tetsuo Fujimaki and Yoshiki Yasukochi and Ichiro Takeuchi and Jun Sakuma},
  journal={Biomedical Reports},
  year={2018},
  volume={9},
  pages={21 - 36}
}
Given that early-onset type 2 diabetes mellitus (T2DM), metabolic syndrome (MetS), and hyperuricemia have been shown to have strong genetic components, the statistical power of a genetic association study may be increased by focusing on early-onset subjects with these conditions. Although genome-wide association studies have identified various genes and loci significantly associated with T2DM, MetS, and hyperuricemia, genetic variants that contribute to predisposition to these conditions in… 

Figures and Tables from this paper

Impact of Genetic Factors on the Age of Onset for Type 2 Diabetes Mellitus in Addition to the Conventional Risk Factors
TLDR
There is a considerable genetic predisposition for the early onset of type 2 diabetes mellitus; therefore, in addition to conventional risk factors, GRS can be used as a tool for estimating the risk of the earlier onset of T2DM and stratifying populations at risk in order to define preventive interventions.
Genome-wide association analysis of metabolic syndrome quantitative traits in the GENNID multiethnic family study
TLDR
This multiethnic family study found genetic heterogeneity and coincident associations (with one case of pleiotropy), highlighting the importance of including diverse populations in genetic research and illustrating the complex genetic architecture underlying MetS.
Positive Selection in Gene Regulatory Factors Suggests Adaptive Pleiotropic Changes During Human Evolution
TLDR
Four of the positively selected GRFs are KRAB-ZNF proteins, that induce changes in target genes co-expression and/or through arms race with transposable elements, which suggest that these GRFs participated pleiotropically to phenotypic adaptations in humans.
Rapid Gout Detection Method and Kit
TLDR
A colorimetric method which is based on the ability of uric acid to reduce silver nitrate is proposed and validated, which has the potential to increase diagnostic efficiency and accelerate patient care at the bedside.

References

SHOWING 1-10 OF 78 REFERENCES
Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease
TLDR
A genome-wide, multi-ancestry study of genetic variation for type 2 diabetes and coronary heart disease finds variants associated with both outcomes implicate new pathways as well as targets of existing drugs, including icosapent ethyl and adipocyte fatty-acid-binding protein.
Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity.
TLDR
Genetic factors and obesity play more significant roles than autoimmunity in familial type 2 diabetes in young Chinese patients, and the significance of obesity-related genes and other gene-gene and gene-environment interactions in these young patients remains to be determined.
Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians
TLDR
The combined analysis identified eight new T2D loci reaching genome-wide significance, which mapped in or near GLIS3, PEPD, FITM2-R3HDML-HNF4A, KCNK16, MAEA, GCC1-PAX4, PSMD6 and ZFAND3, which may regulate glucose-dependent insulin secretion in the pancreas.
Genome-Wide Screen for Metabolic Syndrome Susceptibility Loci Reveals Strong Lipid Gene Contribution But No Evidence for Common Genetic Basis for Clustering of Metabolic Syndrome Traits
TLDR
Genes from lipid metabolism pathways have the key role in the genetic background of MetS, and a genetic risk score, calculated as the number of risk alleles in loci associated with individual MetS traits, was strongly associated with MetS status.
A genome-wide association study identifies novel risk loci for type 2 diabetes
TLDR
Four loci containing variants that confer type 2 diabetes risk are identified and constitute proof of principle for the genome-wide approach to the elucidation of complex genetic traits.
Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi‐stage genome‐wide association study
Metabolic syndrome (MetS), a cluster of metabolic disturbances that increase the risk for cardiovascular disease and diabetes, was because of genetic susceptibility and environmental risk factors. To
Identification of rs7350481 at chromosome 11q23.3 as a novel susceptibility locus for metabolic syndrome in Japanese individuals by an exome-wide association study
TLDR
The polymorphism rs7350481 at chromosome 11q23 may be a novel susceptibility locus for metabolic syndrome in Japanese, and single nucleotide polymorphisms in three genes and at four loci were implicated as candidate determinants of obesity and metabolic syndrome, respectively.
Genome-wide association study identifies African-ancestry specific variants for metabolic syndrome.
Association of genetic variants with hypertension in a longitudinal population-based genetic epidemiological study
TLDR
Longitudinal analysis with a generalized linear mixed-effect model and with adjustment for age, gender, body mass index and smoking status among individuals not taking anti-hypertensive medication revealed that BTN2A1 may be a susceptibility gene for hypertension.
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
TLDR
The data implicate KCNQ1 as a diabetes susceptibility gene in groups of different ancestries as well as in two independent Japanese populations, and the risk allele of this polymorphism was associated with impairment of insulin secretion according to the homeostasis model assessment of β-cell function or the corrected insulin response.
...
...